Citigroup reissued their buy rating on shares of Reckitt Benckiser Group (LON:RB) in a research note issued to investors on Tuesday morning, Stock Target Advisor reports. Citigroup currently has a GBX 8,200 ($100.91) target price on the stock, up from their prior target price of GBX 7,200 ($88.60).
Several other equities research analysts have also issued reports on RB. Societe Generale decreased their price target on shares of Reckitt Benckiser Group from GBX 5,400 ($66.45) to GBX 5,200 ($63.99) and set a sell rating on the stock in a report on Thursday, June 4th. Barclays lifted their price target on shares of Reckitt Benckiser Group from GBX 7,900 ($97.22) to GBX 9,000 ($110.76) and gave the company an overweight rating in a report on Tuesday, June 23rd. Deutsche Bank lifted their price target on shares of Reckitt Benckiser Group from GBX 7,200 ($88.60) to GBX 7,400 ($91.07) and gave the company a buy rating in a report on Friday, May 1st. UBS Group raised shares of Reckitt Benckiser Group to a buy rating and lifted their price target for the company from GBX 5,700 ($70.15) to GBX 8,400 ($103.37) in a report on Monday. Finally, Credit Suisse Group lifted their price target on shares of Reckitt Benckiser Group from GBX 6,100 ($75.07) to GBX 6,850 ($84.30) and gave the company a neutral rating in a report on Friday, June 26th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and thirteen have assigned a buy rating to the company. The stock currently has an average rating of Buy and a consensus target price of GBX 7,117.37 ($87.59).
RB stock opened at GBX 7,432 ($91.46) on Tuesday. The company has a quick ratio of 0.40, a current ratio of 0.56 and a debt-to-equity ratio of 130.80. Reckitt Benckiser Group has a 12 month low of GBX 5,130 ($63.13) and a 12 month high of GBX 8,191.30 ($100.80). The firm has a market cap of $52.69 billion and a P/E ratio of -14.30. The company’s 50-day moving average price is GBX 7,055.16 and its two-hundred day moving average price is GBX 6,393.24.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Further Reading: Understanding each part of a balance sheet
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.